Although the study presented some limitations due to the use of mouse bone-derived cells co-cultured with human cancer cells, it confirmed how soluble factors (among which MCP-1 and IL6) produced by bone cells are chemotactic for BCCs and that the cross-talk between BCCs and bone cells alters the production of molecules by bone cells. The gene discussed is IL6; the disease is cancer.